Metaclipse Therapeutics Corp
CAGE Code: 6BYQ1
NCAGE Code: 6BYQ1
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 967732384
Summary
Metaclipse Therapeutics Corp is an Active Commercial Supplier with the Cage Code 6BYQ1 and is tracked by Dun & Bradstreet under DUNS Number 967732384..
Address
3342 International Park Dr Se
Atlanta GA 30316-4700
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Blue Cross And Blue Shielf Of International Business Machines Corp Econostrip Inc Ellisdon Construction,Inc. Government Technology Services Inc Ericsson Inc Custom Packaging Services Inc Christopher Stallard Cheatom Connected Enterprises Llc Southeast Container Concepts Inc Prudential Health Care Plan Inc Information America Inc Mechanical Specialities Inc Monarch Distributing Inc Epko Industries Inc Mdc Sanstar Productions Inc Multimedia Communication Services Auto-Soler Bostitch Div Of Textron James Auto Transport Inc Xtras Inc
Frequently Asked Questions (FAQ) for CAGE 6BYQ1
- What is CAGE Code 6BYQ1?
- 6BYQ1 is the unique identifier used by NATO Organizations to reference the physical entity known as Metaclipse Therapeutics Corp located at 3342 International Park Dr Se, Atlanta GA 30316-4700, United States.
- Who is CAGE Code 6BYQ1?
- 6BYQ1 refers to Metaclipse Therapeutics Corp located at 3342 International Park Dr Se, Atlanta GA 30316-4700, United States.
- Where is CAGE Code 6BYQ1 Located?
- CAGE Code 6BYQ1 is located in Atlanta, GA, USA.
Contracting History for CAGE 6BYQ1 Most Recent 25 Records
- 75N93019C00017
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- 23 Mar 2022
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,148,210.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00017
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- 13 Aug 2019
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,148,210.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00017
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- 4 Jun 2020
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,148,210.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00017
- Modification To The Article B.2 Prices, Schedule Of Charges.
- 22 Aug 2019
- Modification To The Article B.2 Prices, Schedule Of Charges.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,148,210.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00017
- Modification To Revise Article B.2., Prices, Schedule Of Charges; C.2., Reporting Requirements; F.2., Deliveries; I.2., Authorized Substitution Of Clauses; And I.3., Additional Contract Clauses.
- 25 Nov 2019
- Modification To Revise Article B.2., Prices, Schedule Of Charges; C.2., Reporting Requirements; F.2., Deliveries; I.2., Authorized Substitution Of Clauses; And I.3., Additional Contract Clauses.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,148,210.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00017
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- 25 Aug 2022
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,148,210.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00017
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- 25 Aug 2022
- Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,148,210.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00017
- Eo14042 - Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- 12 Oct 2021
- Eo14042 - Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,148,210.00
- Department Of Health And Human Services (Hhs)
- HHSN272201700062C
- Igf::Ot::Igf Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly
- 31 Jul 2017
- Igf::Ot::Igf Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $230,270.00
- Department Of Health And Human Services (Hhs)
- HHSN272201700062C
- Igf::Ot::Igf Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly
- 6 Sep 2017
- Igf::Ot::Igf Development Of Membrane Anchored Cytokines As Novel Vaccine Adjuvants For The Elderly
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $230,270.00
- Department Of Health And Human Services (Hhs)